An early cancer detection test developed by Pinpoint Data Science Ltd. is one of several to be used in a new trial in the U.K., involving more than 20,000 NHS patients, to assess whether simple blood ...

Moderna Inc. is poised and ready for U.S. FDA approval of its autologous mRNA cancer vaccine, intismeran, and its hoped-for ...

The U.S. FDA approved Pimjetmi (pimicotinib) from Merck KGaA and Abbisko Therapeutics Co. Ltd., making it the third CSF-1R ...

Heidi Overton could move one step closer to becoming the next U.S. FDA commissioner Nov. 18. That’s when the Senate Health, Education, Labor and Pensions (HELP) Committee has scheduled a vote on ...

Two differing development paths with separate mechanisms of action in Sjogren’s disease were highlighted in late-stage data at the American College of Rheumatology meeting by Amgen Inc. and Novartis ...

Another China-originated drug candidate is heading toward Western public markets. Windward Bio AG is seeking $175 million in a U.S. IPO to fund late-stage development of WIN-378, its long-acting ...

Biopharma deal value fell 38.5% in the third quarter (Q3) of 2026 to $55.55 billion, down from the record $90.4 billion in Q2 ...

Once the dominant force in pharma, Europe is now in the squeezed middle, caught between the commercial dominance of the U.S.